TIE aim of the present study was to compare serum levels of soluble forms of interleukin-2 receptor, CD4 and CD8, released by lymphocytes during activation of the immune system, in patients with histologically verified chronic active hepatitis associated to hepatitis C virus infection, with those in healthy subjects. Significantly higher levels of soluble IL-2R and soluble CD8 were found in patients with chronic active hepatitis compared with controls. In contrast no difference was found for soluble CD4 values in the two groups. No correlations were found for both sIL-2R and sCD8 and these two molecules with other parameters of liver function. These results indicate that in these patients there is a general activation of the immune system, but the lack of correlation with parameters of liver function strengthens the suggestion that this activation does not play a role in the pathogenesis of chronic type C hepatitis.
Introduction
During activation, lymphocytes secrete glycoproteins related to their surface proteins, including interleukin-2 receptor (IL-2R), CD4 and CD8 soluble forms. These glycoproteins are found in relatively large amounts in the circulation and it is possible to obtain normal ranges for normal persons, with upper limits. This allows the detection of states of increased production of soluble interleukin-2 receptor (sIL-2R), soluble CD4 and CD8 (sCD4 and sCD8) corresponding to increased activation of the immune system. Increased levels of a soluble form of these glycoproteins have been observed in the serum of patients with malignant, autoimmune 
Results
Patients with chronic type C hepatitis have significantly higher levels of sIL-2R than do normal controls (Table 1) . For the soluble forms of CD4 and CD8, sCD8 levels were significantly increased in patients, whereas for sCD4 no significant difference was observed between the two groups, as shown in Table  1 . It is interesting to note that in spite of the simultaneous increase of both slL-2R and sCD8, no correlation was demonstrated between the levels of these two molecules (r= 0.25; p= n.s.). In addition, no significant correlation between serum levels of slL-2R In a small number of patients, available for a second observation after 6 months, the sera showed mean levels of these soluble molecules almost identical to those of the first observation ( Table 2) .
Discussion
The present results demonstrate that in patients affected by chronic type C hepatitis there is a significant increase of slL-2R and sCD8 but not of sCD4. This increase is present during the whole course of the disease as demonstrated by the fact that a second assay of these soluble molecules on the sera of the same patients 6 months later showed no significant changes.
Serum sIL-2R has been measured in patients affected by several liver diseases. All patients with acute type B hepatitis presented levels significantly higher than that of normal controls or of patients with chronic type B hepatitis. Serial follow-up showed that serum levels of slL-2R tended to return to normal 2-4 months after onset of acute hepatitis together with the ALT normalization. Patients with chronic type B hepatitis also had significantly higher levels of sIL-2R that varied considerably with liver flogosis, i.e. significantly lower levels were detected in patients with chronic infection who had no evidence of active liver disease. In chronic infection, in response to therapy with prednisone and/or interferon, serum sIL-2R fell significantly and a significant correlation between serum sIL-2R and ALT levels has been observed. High slL-2R levels have also been observed during hepatitis A infection, while lower values have been seen during acute hepatitis C infection.
Soluble IL-2R has also been measured in the serum of patients with liver cirrhosis, patients with obstructive jaundice and patients with alcoholic liver disease without evidence of cirrhosis. In patients with cirrhosis and obstructive jaundice sIL-2R was significantly increased compared with healthy subjects. No difference was found between patients with cirrhosis due to alcohol abuse and chronic hepatitis B. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In obstructive jaundice, sIL-2R correlated with alkaline phosphatase as a marker of cholestasis. 3 Serum soluble molecules in chronic HCV hepatitis Concerning serum sCD8 levels, this glycoprotein was increased in patients with cirrhosis but not in patients with obstructive jaundice, compared with healthy subjects and patients with unrelated diseases. No difference was found between patients with cirrhosis due to alcohol abuse and chronic hepatitis B. [12] [13] [14] [15] On the whole these data show that in spite of the apparent well-known depressed cellular immune response both in liver cirrhosis and obstructive jaundice 14 
